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Abstract
Fatty acids can act as important signaling molecules regulating diverse physiological processes. Our understanding,
however, of fatty acid signaling mechanisms and receptor targets remains incomplete. Here we show that Transient
Receptor Potential Ankyrin 1 (TRPA1), a cation channel expressed in sensory neurons and gut tissues, functions as a sensor
of polyunsaturated fatty acids (PUFAs) in vitro and in vivo. PUFAs, containing at least 18 carbon atoms and three unsaturated
bonds, activate TRPA1 to excite primary sensory neurons and enteroendocrine cells. Moreover, behavioral aversion to PUFAs
is absent in TRPA1-null mice. Further, sustained or repeated agonism with PUFAs leads to TRPA1 desensitization. PUFAs
activate TRPA1 non-covalently and independently of known ligand binding domains located in the N-terminus and 5
th
transmembrane region. PUFA sensitivity is restricted to mammalian (rodent and human) TRPA1 channels, as the drosophila
and zebrafish TRPA1 orthologs do not respond to DHA. We propose that PUFA-sensing by mammalian TRPA1 may regulate
pain and gastrointestinal functions.
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exogenous and endogenous fatty acids by nerves and other cells
represents a fundamental physiological process. For example, taste
receptorcellsandenteroendocrinecellsofthegastrointestinalsystem
sense dietary fatty acids to regulate proper digestive processes and
appetite[1].Further,thesensingofphospholipid-derivedfattyacidsis
a critical signaling pathway. Phospholipase A2 enzymes hydrolyze
glycerophospholipidstoreleaseafreePUFA[2].Additionally,diacyl
glycerol (DAG) lipase may liberate a PUFA from DAG. In turn,
PUFAs and their metabolites act on various targets to regulate
inflammation, cell division and wound repair [3,4].
Despite the importance of fatty acid signaling the molecular
identity of critical fatty-acid sensors is unclear. Cluster of
differentiation-36 (CD36) expressed in taste papillae binds
saturated and unsaturated fatty acids and participates in
orosensory-mediated digestive secretions [1]. Unsaturated fatty
acids can also block delayed rectifier K
+ channels to prolong
depolarization of taste receptor cells [5]. Further, enteroendocrine
tissue express several orphan GPCRs: GPR40 [6], GPR41 [7,8],
GPR43 [7,8] and GPR120 [9] that are believed to participate in
the sensing of saturated and unsaturated fatty acids. Finally,
polyunsaturated fatty acids bind peroxisome proliferator-activated
receptors to regulate gene expression [10].
Interestingly, Transient Receptor Potential (TRP) ion channels
are candidate fatty acid sensors [11]. Phospholipase C signaling
coupled to diacylgylcerol (DAG) activates Drosophila TRP and
TRPL [11] as well as vertebrate TRPC 2, 3, 6 and 7 channels
[12]. Further, polyunsaturated fatty acids (PUFAs), specifically
linolenic acid, directly gate Drosophila TRP and TRPL [13] while
20-carbon PUFAs activate C. elegans TRPV channels [14].
Moreover, PUFAs can sensitize, activate or inhibit vertebrate
TRP channels including TRPV1 [15], TRPV3 [16] and TRPM8
[17]. The precise physiological relevance of fatty-acid sensing by
TRP channels is unclear.
Here we identify mammalian TRPA1 as a PUFA receptor.
TRPA1, expressed primarily in nociceptive sensory neurons [18],
detects a variety of noxious electrophilic compounds including
mustardoil(allylisothiocyanate,AITC)[19],[20],cinnamaldehyde
[20], wasabi [19], and 4-hydroxynonenal, an endogenous un-
saturated aldehyde [21]. In addition, several chemicals activate
TRPA1inanon-covalentfashionincludingicilin[22],menthol[23],
andnoxiousgeneralanesthetics[24].Ofnote,disruptionofTRPA1
expression attenuates pain-hypersensitivity indicating an important
roleforTRPA1innociception[18].Inaddition,TRPA1expression
invariousguttissues(intrinsicentericneurons[25],inhibitorymotor
neurons [26] and enteroendocrine cells [27,28,29]) suggests novel,
non-nociceptive functions for TRPA1 that remain to be elucidated.
WeshowthatTRPA1mediatesPUFA-inducedexcitationofsensory
neuronsandenteroendocrinecells,aswellasPUFA-inducedaversive
behaviors in mice. PUFAs directly activate, in a non-covalent
manner,mammalianTRPA1butdonotactivatethedrosophilanor
zebrafish channel orthologs. These data, establish mammalian
TRPA1 asa PUFA detectorboth in vitro and in vivo.
Results
TRPA1 is Critical for Sensing PUFAs in Sensory Neurons
In our search for novel fatty acid receptors we were guided
by the observation that PUFAs have an aversive quality both in
worms [14] and mammals [30]. To explore whether this
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38439property arises from a direct activation of nociceptors, we
performed Ca
2+ imaging in cultured, mouse sensory neurons.
Figure 1A&E shows that docosahexaenoic acid (DHA, C22:6),
increased intracellular [Ca
2+] in a subset (17.5%, 25 of 143
cells) of sensory neurons. In contrast, the saturated fatty acid,
lauric acid (LA,C12:0), elicited little response (3.4%, 2 of 58
cells; Fig. 1E and Fig. S1). Strikingly, these DHA-sensitive
neurons all responded to AITC, an agonist of the TRPA1
channel (Fig. 1B). In contrast, no responses to DHA were
observed in AITC-insensitive neurons (Fig. 1C). To test a critical
role for TRPA1 in sensing DHA, we examined sensory neurons
derived from TRPA1-deficient mice. Figure 1D&E shows that
DHA-evoked responses were mostly absent in these cells (1.7%,
1 of 60 cells), whereas these TRPA1-null cells displayed
sensitivity to capsaicin (26.7%, 16 of 60 cells), a ligand for
the TRPV1 channel that is commonly co-expressed with
TRPA1 [18]. Thus, TRPA1 appears critical for sensory nerves
to detect PUFAs. Although we showed previously that PUFAs
activate TRPV1 [15], this agonistic effect required concomitant
protein kinase C-mediated phosphorylation that sensitizes
TRPV1 to various agonists. Under resting non-inflammatory
conditions, therefore, TRPA1 is the predominant sensor of
PUFAs.
TRPA1 Mediates Taste-aversion to PUFAs in Mice
To test whether TRPA1 contributes to oral aversion to fatty
acids we performed two-taste preference tests. Mice trained to eat
a sweetened, flavored gelatin, were presented with gelatin
supplemented with or without DHA (0.5 and 5 mM). Figure 2A
shows that wild-type mice showed a negative preference to DHA
at 5 mM, whereas TRPA1-mice in contrast, displayed no
preference. Although fatty acid texture could contribute to taste
preferences, we found that wild-type mice preferred lauric acid to
DHA in a two-taste preference test (Fig. 2B), arguing against non-
specific textural effects of DHA. Further, if given no choice, mice
consumed similar amounts of gelatin with or without DHA
(Fig. 2C) arguing against strict avoidance of DHA. Thus, TRPA1
appears essential for the sensory nerve detection of PUFAs in vivo
and accompanying behavioral responses.
PUFAs Activate Mammalian TRPA1 Channels
To explore if DHA directly activates TRPA1 we performed
voltage-clamp experiments in TRPA1-expressing HEK293 cells.
Figure 3A shows that DHA (100 mM) evoked an outwardly-
rectified current that reversed near 0 mV, consistent with
activation of TRPA1. Immediate application of AITC (1 mM)
to this cell enhanced the current at negative potentials, generating
a voltage-insensitive response typical of a high concentration of
agonist [31]. In contrast, DHA failed to evoke currents in mock-
transfected cells (n=3). Potentially, activation of TRPA1 could
involve DHA itself, or a DHA metabolite. Indeed, unsaturated
fatty acids can oxidize in aqueous solutions to form electrophiles,
and electrophilic compounds can covalently modify and activate
TRPA1 [22,32]. Therefore, to exclude an electrophilic effect we
co-applied the anti-oxidant N-acetyl-L-cysteine (NAC). Figure 3B
shows that co-application of NAC (15 mM) fully suppressed
activation by the TRPA1 agonist, AITC, demonstrating that NAC
can effectively sequester electrophiles under these conditions. In
contrast, DHA and eicosapentaenoic acid (EPA, C20:5, 100 mM)
evoked robust currents in the presence of NAC or ascorbic acid
(Figs. 3C&D) indicating unambiguously that these PUFAs, and not
oxidized products, stimulate TRPA1. Concentration-response
analysis for DHA (at 260 mV, Fig. 3E) revealed an EC50 of
41 mM with an efficacy of ,50%. Interestingly, membrane
depolarization to +120 mV increased the efficacy and potency to
100% and 9 mM respectively, consistent with the ability of TRPA1
[23] and other thermosensitive TRP channels to synergistically
integrate physical (voltage) and chemical stimuli [31,33]. Thus,
Figure 1. TRPA1 is critical for sensory nerve detection of PUFAs. (A) Fluo-4 fluorescence images of DHA-responsive neurons (top panel) and
a non-responsive neuron (bottom panel). Scale bar is 40 mm. (B&C) Representative Ca
2+ transients evoked by DHA (100 mM), AITC (1 mM), KCl
(140 mM) in DRG neurons (B, DHA responsive; C, DHA-unresponsive). (D) Ca
2+ transients evoked by DHA (100 mM) or capsaicin (CAP, 100 nM) in DRG
neurons from TRPA1-null mice. (E) The percentage of WT or TRPA1-null neurons responsive to DHA (WT, n=25 of 143; TRPA1-null, n=1 of 60), LA
(WT, n=2 of 58), AITC (WT, n=39 of 201) or CAP (TRPA1-null, n=16 of 60).
doi:10.1371/journal.pone.0038439.g001
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synergize with other TRPA1 stimuli.
TRPA1 is well known to undergo Ca
2+-dependent desensitiza-
tion. As seen with other agonists, we found that DHA-evoked
currents exhibited a rapid component of decay during DHA
application and also a reduction in the peak responses with
repeated application (tachyphylaxis) (Fig. 3G). Interestingly, re-
peated DHA applications largely inhibited subsequent responses to
AITC (500 mM, Fig. 3G.) To quantify this effect, we measured
AITC-evoked Ca
2+ responses in HEK293 cells with or without
pretreatment with DHA. Figure 3F shows that DHA (100 mM for
10 minutes) reduced the response to AITC by ,70%. We also
found that pre-treatment with AITC (500 mM) completely
inhibited subsequent responses to DHA (100 mM) in voltage-
clamped HEK293 cells (260 mV, n=4).
Next, we investigated the structural requirements for fatty acid
activation of TRPA1 by comparing effects of fatty acids with
varying carbon chain length and unsaturation. Figure 4 shows that
activation of TRPA1 requires the presence of at least three double
bonds, and maximal activity is obtained with four double bonds
and twenty carbon atoms. Additionally, n23 and n26 PUFAs
produced equivalent activation.
The nociceptive function of TRPA1 is remarkably conserved
across animal species; insects to humans employ TRPA1 as
a sensor of harmful electrophiles [34]. We therefore asked if fatty
acid sensing is similarly conserved. Figure 5 and Fig. S2 show that
DHA (100 mM) robustly activates mouse, rat and human TRPA1,
with maximal efficacy at potentials greater than +100 mV.
Surprisingly, and in contrast, DHA (100 mM) evoked little to no
activation of drosophila or zebrafish (Zebrafish A&B) TRPA1 at
both negative and positive potentials. This concentration of DHA
is ,8–10-fold higher than the EC50 value measured in rat
(+120 mV see Fig. 3E). Thus, fatty acid sensing appears to be
selective for mammalian TRPA1 channels.
PUFAs Activate TRPA1 via an Intracellular-accessible
Domain and Independently of the N-terminus and
Transmembrane 5
Next, we explored potential mechanisms for PUFA activation of
TRPA1. First, we considered whether or not PUFAs act on the
plasma membrane and independently of the TRPA1 protein.
Indeed, unsaturated fatty acids can increase membrane fluidity/
elasticity [35] and this property could potentially underlie
activation of TRPA1. However, we found that the micelle-forming
detergent and membrane fluidizer, Triton X-100 (50 mM) [36],
produced negligible activation of TRPA1 at negative or positive
potentials (0.360.2% and 161% of AITC at 260 mV and
+100 mV respectively, n=3), arguing against membrane fluidity
effects.
Next, we explored for regions in TRPA1 necessary for fatty
acid agonism. To discriminate between an extracellular and
intracellular mode of action, we compared effects of the
coenzyme A derivative of DHA, DHA-CoA. The addition of
coenzyme A increases the hydrophilicity of the fatty acid,
effectively rendering it membrane impermeable. Figure 6A
shows that extracellular application of DHA-CoA failed to
activate TRPA1. In contrast, intracellular application of DHA-
CoA (by inclusion in the patch pipette solution) evoked currents
similar to DHA. These data indicate that DHA engages TRPA1
at the cytoplasmic face or in the inner leaflet of the membrane.
Structure-function studies have revealed two broad domains
required for ligand activation of TRPA1. The N-terminus
contains several cysteines and a lysine essential for activation by
Figure 2. TRPA1 mediates taste aversion to PUFAs. (A) Percentage consumption of gelatin with or without DHA (0.5 or 5 mM) in a two-taste
preference test by wild-type (n=10) or TRPA1-null mice (n=7). *p,0.05 T-test. (B) Percentage consumption of DHA (5 mM) or LA (5 mM, n=3) in
a two-taste preference test. (C) Percentage of DHA (5 mM) or LA (5 mM) consumed in a single taste test compared to lipid-free gelatin consumed the
previous day (wild-type only, n=4).
doi:10.1371/journal.pone.0038439.g002
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th trans-
membrane domain (TM5) mediate sensitivity to the non-
covalent ligand, menthol [37]. To test a role for these domains
in fatty-acid sensing we studied TRPA1 chimeras composed of
drosophila (DHA-insensitive) and mouse (DHA-sensitive) pro-
teins (Figs. 6B–E). Figure 6D shows that substituting the mouse
N-terminus fails to confer DHA-sensitivity to dTRPA1, although
the chimera responds robustly to AITC. Thus, the N-terminus
alone is not sufficient for detecting DHA. Further, exchanging
mouse TM5 with the dTM5 did not affect sensitivity to DHA
(Fig. 6E). Thus, neither the N-terminus nor TM5 appear to be
directly involved in fatty acid sensing.
DHA Activates TRPA1 and Secretion in
Enteroendocrine Cells
Interestingly, in addition to sensory nerves, TRPA1 is found in
enteroendocrine cells of the mammalian gut. In situ hybridization
identifies TRPA1 in epithelial cells facing the gut lumen [27]. In
particular, enterochromaffin cells (ECs) [27], the EC-like cells
lines, RIN14B [27] and QGP-1 [28], and the I-cell line STC-1
[29] highly express TRPA1. We therefore tested effects of AITC
and DHA in several EC cell lines (obtained from American Type
Culture Collection). Electrophysiological measurements of
TRPA1 in STC-1 cells have not been reported previously.
Therefore we first confirmed TRPA1 functionality by measuring
Figure 3. DHA activates rat TRPA1 in transfected HEK293 cells. (A) Representative I–V relationship for DHA (100 mM) and AITC (1 mM) in
a voltage-clamped TRPA1-expressing HEK293 cell. (B&C) N-acetyl-L-cysteine (NAC, 15 mM) prevents the activation of TRPA1 current by AITC (1 mM)
but not DHA (100 mM). (D) Normalized EPA-evoked currents (% of 1 mM AITC) in control buffer (n=4), NAC (15 mM, n=4), or Ascorbic Acid (15 mM,
n=4). (E) DHA activates TRPA1 currents in a dose- and voltage-dependent manner (n=3–5; holding potential 260 mV or +120 mV). The smooth lines
show the best-fits to a Hill equation yielding an Emax of 4966%, EC50 of 4165 mM and Hill Coefficient of 3.861.3 for 260 mV, and Emax of 100%, EC50
of 13.261.8 mM and Hill Coefficient of 1.060.1 for +120 mV. (F) Normalized increase in intracellular [Ca
2+] evoked by AITC in TRPA1-expressing
HEK293 cells with or without pre-treatment with DHA (100 mM, 10 min, n=40–50). DHA was washed out for 2 min prior to AITC challenge. (G)
Representative currents evoked by repeated application of DHA (100 mM) and AITC (500 mM) in a voltage-clamped TRPA1-expressing HEK293 cell.
doi:10.1371/journal.pone.0038439.g003
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AITC activates an inward current (260 mV) and this response
exhibits characteristic desensitization. Concentration-response
analysis (Fig. 7B) revealed an EC50 of 29 mM and Hill slope of
1.2, similar to values previously reported for rodent TRPA1
expressed heterologously (11–33 mM [19,20]). Next, we examined
the sensitivity of EC cells to PUFAs. Figure 7C–E shows that DHA
activates an outwardly-rectified conductance in voltage-clamped
STC-1 and RIN14B cells, that is inhibited by the TRPA1
antagonist, HC030031. Finally we measured secretion of the gut
hormone, cholecystokinin (CCK). Figure 7F shows that the
TRPA1 agonists, DHA and AITC evoke robust secretion of
CCK from STC-1 cells. In contrast, the saturated fatty acid, LA,
elicits a significantly smaller level of release. Notably, DHA-evoked
CCK release was inhibited by HC030031 (Fig. 7F). In addition,
we found that pre-treatment with AITC to functionally ablate
TRPA1 responses decreased CCK secretion by 57612% (n=3,
P,0.01). In these experiments we pre-applied AITC in the
presence of ruthenium red (10 mM) to avoid Ca
2+-triggered
depletion of CCK, and we found that AITC did not affect the
maximal depolarization-evoked CCK release which was ,20-fold
under control or pre-treated conditions. Taken together, these
data show that TRPA1 confers sensitivity to PUFAs in
enteroendocrine cells and direct activation of TRPA1 by DHA
contributes to CCK secretion.
Discussion
Our data identify mammalian TRPA1 as a molecular detector
of PUFAs. Although PUFAs are known to modulate several TRP
channels the precise physiological functions of these effects are
unclear. We show that PUFAs activate TRPA1 and that TRPA1 is
essential for PUFAs to excite sensory neurons and enteroendocrine
cells. Moreover, behavioral aversion to oral ingestion of PUFAs
requires TRPA1 and is defective in TRPA1-null mice.
Comparative analysis of fatty acid structures showed that both
the level of unsaturation and carbon-chain length determine fatty
acid activity at TRPA1. Activation of TRPA1 requires a minimum
of three double bonds and maximum efficacy occurs with four
double bonds and twenty carbon atoms. Thus, AA, EPA and
DHA possess approximate equivalent efficacy. DHA, unlike AA
and EPA, is poorly metabolized and therefore these data support
a direct action of fatty acids rather than PUFA metabolites. This is
consistent with an earlier Ca
2+ imaging study showing that both
AA and a non-metabolizable AA congener stimulate TRPA1
expressed in HEK293 cells [20]. Unsaturated fatty acids are
susceptible to auto-oxidation resulting in the formation of various
electrophilic derivatives [38] that could potentially explain
activation of TRPA1. In addition, nitrated fatty acids containing
a nitroalkene group potently activate TRPA1 [39,40], while
oxidized linoleic acid metabolites activate TRPV1 [41]. However,
we found that PUFAs retained activity even in the presence of high
concentrations of NAC that is effective in fully sequestering
electrophiles such as AITC. PUFAs are membrane fluidizers
[35,36] and increased membrane fluidity could therefore account
for opening of TRPA1. We observed, however, that another
membrane fluidizer, Triton-X 100 exerted little effect on TRPA1
activity. Furthermore, increasing the hydrophilicity, and thereby
restricting the membrane penetrance, of DHA with addition of
a Coenzyme A group did not abolish PUFA agonism, arguing
against a non-specific effect on membrane properties. Thus, the
most parsimonious explanation is that PUFAs act directly on the
Figure 4. Activation of TRPA1 depends on fatty acid chain length and unsaturation. (A) Structures of fatty acids. (B) Normalized currents
(% of 1 mM AITC) evoked by fatty acids (100 mM) at 260 or +100 mV in HEK293 cells transfected with rat TRPA1 (n=4–8).
doi:10.1371/journal.pone.0038439.g004
Figure 5. DHA selectively activates mammalian TRPA1 chan-
nels. (A) Normalized responses to 100 mM DHA at 260 and +100 mV in
HEK293 cells transfected with either drosophila, zebrafish A, zebrafish B,
mouse, rat or human TRPA1 (n=3–6).
doi:10.1371/journal.pone.0038439.g005
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activity, and competitively displace [
3H]-resiniferatoxin binding,
suggesting that PUFAs directly interact with TRPV1 [15].
The results of previous studies have identified two domains in
TRPA1 involved in ligand sensing. The N-terminus contains
several cysteines and a lysine required for covalent modification by
electrophiles [22,32]. Interestingly, thermal sensing in snake
TRPA1 may also reside in the N-terminal ankyrin repeat domains
[42]. Outside of the N-terminus the fifth transmembrane domain
(TM5) is implicated in menthol- and thymol-sensing [37].
Surprisingly, our analysis using chimeric drosophila-mouse
TRPA1 channels suggests that neither the N-terminus nor TM5
is directly involved in sensing PUFAs. Rather these data suggest
that other transmembrane or intracellular domains contain PUFA
interaction sites. However, we can not exclude the possibility that
the N-terminus acts in concert with these other regions. Un-
fortunately, the non-functionality of many of the mammalian-
drosophila chimeras [37] restricted further exploration of putative
PUFA-sensing domains. Nonetheless, the species-specific differ-
ences in PUFA activation of TRPA1 may prove useful in
determining critical sites required for PUFA sensing. Interestingly,
lipoxygenase-generated DHA derivatives, termed resolvins, are
reported to be TRPA1 antagonists [43]. Resolvin D1 blocks
TRPA1 in a non-competitive fashion [43], and potentially PUFAs
and their derivatives act at the same site to affect channel gating in
a positive or negative manner.
Although the precise physiological role of PUFA-sensing by
TRPA1 is unclear, our data suggest potential roles in nociceptive
signaling and/or gut function. The generation of PUFAs such as
AA following stimulation of PLA2 activity is a fundamental
signaling pathway in inflammation and pain. Activated cytosolic
PLA2 hydrolyzes the sn-2 position of glycerophospholipids to
release AA and lysophospholipid. Further, diacylglycerol lipase
can liberate AA from diacylglycerol. In turn, this AA may directly
activate TRPA1, in addition to being metabolized by cycloox-
ygenase, lipoxygenase or P450 enzymes into algesic products and
electrophilic TRPA1 agonists [44,45]. Although the absolute
sensitivity of PUFA activation at TRPA1 appears low (EC50 of
41 mMa t260 mV), it is on par with that reported for the
prostaglandin agonists [44,45]. In addition, it is important to note
that this EC50 reflects extracellular application of fatty acid and the
effective biologic concentration may be much lower. Indeed,
PUFAs likely act at the cytoplasmic face based on the efficacy of
intracellular DHA-CoA. Thus, in sensory neurons, near-mem-
brane microdomains of AA may be sufficient to effectively activate
TRPA1. In addition, PUFAs may act in concert with other
ligands, for example, cytoplasmic Ca
2+ [19,46,47,48] and voltage
[23] that enhance PUFA potency and/or efficacy at TRPA1.
Indeed, we observed that that membrane depolarization increases
efficacy to 100%. Interestingly, Ca
2+ is a key activator of cPLA2.
Therefore, an increase in cytoplasmic [Ca
2+] (a weak TRPA1
stimulus) may synchronize with the generation of AA to produce
a greater TRPA1 response. On the otherhand, we show that
sustained DHA application leads to desensitization of TRPA1,
raising the possibility that PUFAs may exert a predominant
analgesic action. In addition, agonism of TRPA1 by PUFAs (that
Figure 6. PUFAs activate TRPA1 independently of the N-terminus or transmembrane domain 5. A. Mean current responses in rTRPA1-
expressing HEK293 cells (+100 mV; n=3–4) for control, extracellular DHA (20 mM or 100 mM) and DHA-CoA (100 mM), or intracellular application of
DHA-CoA (20 mM) and DHA (20 mM). The background current is not subtracted. (B–E) I–V relationship for responses to DHA (100 mM) and AITC
(1 mM) in HEK293 cells expressing chimeric drosophila-mouse TRPA1 channels.
doi:10.1371/journal.pone.0038439.g006
TRPA1 and Fatty Acids
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as oxidized PUFAs, contribute to the unpleasant ‘‘fishy’’ taste of
spoiled fish [30]. Our data indicate that taste aversion to PUFAs
occurs via TRPA1. Presumably this is mediated by activation of
TRPA1-expressing trigeminal nerves that innervate the oral cavity.
Similarly, caffeine produces taste aversion in rodents through
activating TRPA1 [50]. In contrast, PUFAs produce aversive
behavior in C. elegans via TRPV channels [14], consistent with the
worm TRPA1lacking PUFA sensitivity.
Most dietary fatty acids are liberated from triglycerides in the
small intestine by pancreatic lipases, generating high concentra-
tions of FFAs and monoacylglycerols in the gut lumen.
Enteroendocrine cells facing the gut lumen, detect these FFAs
and other nutrients and in turn secrete gut hormones such as 5-
HT and CCK that regulate gut motility, gut secretions,
gallbladder contraction and gastric emptying [51,52]. Notably,
enteroendocrine cells express functional TRPA1 channels that can
trigger secretion of CCK [29] or 5-HT [27]. In turn, TRPA1-
mediated secretion of 5-HT induces smooth muscle contraction
[27] and modulates gastric emptying [28]. We show that PUFAs
activate TRPA1 in enteroendocrine cell lines and evoke CCK
secretion. Thus, TRPA1 could function as a gut nutrient sensor,
detecting PUFAs to elicit appropriate hormonal responses. In this
regard, it is interesting to note that mammals are obligate
consumers of C20–22 dietary PUFAs during early post-natal
development. Neonates have impaired capacity to synthesize
PUFAs (by desaturating and elongating linoleic acid) [53,54], and
therefore preferentially obtain AA, EPA and DHA directly from
breast milk. Neonates also have less efficient fat absorption [55].
Therefore, it would be interesting to assess a role for TRPA1 in
PUFA-sensing in the neonate gut. For example, PUFA-sensing by
TRPA1-expressing enteroendocrine cells could prolong gastroin-
testinal transit time, an effect that would be adaptive in neonates.
In addition to enteroendocrine cells, intrinsic enteric neurons [25],
inhibitory motor neurons [26] and gut projecting primary afferent
neurons (DRG and vagal) [56,57] all express TRPA1, but it is
doubtful that these are relevant targets for dietary PUFAs.
In summary, our data show that mammalian TRPA1 acts as
a discrete sensor of long-chain PUFAs and TRPA1 confers cellular
and behavioral sensitivity to PUFAs.
Materials and Methods
All experimental procedures involving animals were approved
by the Georgetown University Animal Care and Use Committee
(#07–124) and conform to NIH guidelines.
Figure 7. DHA activates TRPA1 and secretion in enteroendocrine cells. (A) Representative current trace showing response of voltage-
clamped STC-1 cell to successive applications of AITC (500 mM). (B) Concentration-response curve for AITC evoked currents in STC-1 cells (260 mV,
n=3–4 for each point). The smooth lines show the best-fit to a Hill equation yielding an EC50 of 2963 mM and Hill Coefficient of 1.260.1 (C) DHA
(100 mM) activates an inward current in an STC-1 cell that is blocked reversibly by HC030031 (20 mM). (D) I–V relationship in a voltage-clamped STC-1
cell demonstrating response to DHA (100 mM) and block by the TRPA1 antagonist, HC030031 (50 mM). (E) I–V relationship for DHA (100 mM) with and
without HC030031 (50 mM) in a voltage-clamped RIN14B cell. (F) CCK secretion from STC-1 cells stimulated by 100 mM DHA, DHA plus 50 mM
HC030031, 500 mM LA, 100 mM AITC and 140 mM KCl (n=4–12) T-test **p,0.01.
doi:10.1371/journal.pone.0038439.g007
TRPA1 and Fatty Acids
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2+ Imaging
Dorsal root ganglia (DRG) were cultured from adult mice
(mixed background B6/129P wild-type and TRPA1-null
(B6;129P-Trpa1
tm1Kykw/J), Jackson Labs, 12–16 weeks) in Neuro-
basal supplemented with 2% B-27 medium (Invitrogen), 0.1% L-
glutamine and 1% penicillin/streptomycin. Neurons were loaded
with 1 mM Fluo4-AM (Invitrogen) for 20 min and washed for
another 10–20 min before recording. The dye was excited at
480615 nm. Emitted fluorescence was filtered with a 535625 nm
bandpass filter, captured by a SPOT RT digital camera (Di-
agnostic Instruments) and read into a computer. Analysis was
performed offline using Simple PCI software (Compix Inc.).
Electrophysiology
HEK 293F cells (obtained from American Type Culture
Collection) were transfected with drosophila TRPA1 (gift of Paul
Garrity, Brandeis University), zebrafish A and B TRPA1 (gift of
Alex Schier, Harvard University), mouse TRPA1 (gift of Jaime
Garcı ´a-An ˜overos, Northwestern University), rat TRPA1 (gift of
David Julius, University of California San Francisco), human
TRPA1 (gift of Sven Jordt, Yale University), or chimeric
drosophila-mouse TRPA1 (gift of Ardem Patapoutian, The
Scripps Research Institute). STC-1 cells (from American Type
Culture Collection) were cultured in high glucose DMEM
(Hyclone) supplemented with 15% horse serum, 2.5% FBS, 1%
L-glutamine, 1% penicillin/streptomycin. RIN14B cells (from
American Type Culture Collection) were cultured in high glucose
RPMI 1640 supplemented with 10% FBS, 1% L-glutamine and
1% penicillin/streptomycin. Whole cell and single-channel patch-
clamp recordings were performed using an EPC8 amplifier
(HEKA Electronics). For whole-cell recordings the bath solution
contained 140 mM NaCl, 4 mM KCl, 1 mM MgCl2,
1.2 mM CaCl2, 10 mM HEPES, 5.6 mM glucose, pH 7.3.
15 mM N-acetyl cysteine was added to bath solutions containing
DHA. The pipette solution contained 140 mM NaCl or CsCl,
10 mM HEPES, 5 mM EGTA, pH 7.3. Solutions were applied
via a gravity-fed system and separate outlets were used to apply
fatty acids, capsaicin and AITC solutions to prevent cross-
contamination. Concentration-response data were measured by
application of DHA followed immediately by a saturating
concentration of AITC, and data were normalized to AITC.
Current-voltage measurements consisted of a 150-ms ramp from
2150 mV to +150 mV for transfected HEK293 and STC-1 cells.
For RIN14B cells we used a 1 second pre-pulse to +70 mV to
desensitize sodium channels prior to a 150-ms ramp from
250 mV to +150 mV. Unless otherwise stated the baseline
currents under control conditions were subtracted.
CCK Secretion
STC-1 were plated on 35610 mm plates and cultured for 2–3
days. Cells were washed twice with 1 ml HBBS and incubated for
20 min at room temperature with HBBS containing stimulants
(625 ml/well). Supernatants were collected and spun to remove
cell debris. CCK was detected using an EIA kit (Phoenix
Pharmaceutical). Stimulated cells were lysed and analyzed for
total protein using a Bradford assay. Peptide secretion was
normalized to total protein for each plate.
Behavioral Tests
Mice were housed in groups and had access to food and water
ad libitum. Male and female were individually placed in an empty
cage and allowed to acclimate for 30 min before testing. Prior to
the testing day, mice were trained to eat gelatin from two dishes
within 60 min. Only mice that consumed equally from both dishes
were included. The gelatin contained 10% (w/v) Polycose (Ross
Nutrition/Abbot), 2.5% (w/v) gelatin (Knox/Kraft Foods), 2.5%
(w/v) sucrose, and 0.04% (v/v) orange flavoring (McCormick &
Co., Inc.). On testing day the gelatin was supplemented with fatty
acids at varying concentrations based on Cartoni et al. [58]. We
used flavored gelatin to minimize effects of fatty acid texture and
smell.
Fatty acids and Chemicals
Capsaicin (CAP) and HC030031 were obtained from Tocris
Bioscience (Ellisville, MO, USA). Allyl isothiocyanate (AITC),
stearic and lauric acid were purchased from Sigma-Aldrich. Oleic,
linoleic a-linolenic, stearidonic, v-3 and v-6 arachidonic acids,
DHA, and EPA with 0.1% BHT, were obtained from Cayman
Chemical (Ann Arbor, MI, USA). Stock solutions of drugs were
prepared in ethanol and diluted to physiological solution prior to
the experiments; final ethanol concentration was always ,0.1%,
which had no effect on TRPA1 activity. Fatty acids are readily
oxidized in aqueous solutions therefore, the antioxidant, N-acetyl
L-cysteine (15 mM), was added and fresh solutions were made
every 20 min. In some experiments BSA (0.01%) was added to
improve fatty acid solubility.
Supporting Information
Figure S1 Saturated fatty acids do not activate sensory
neurons. (A&B) Lauric acid (LA, 100 mM) evokes little change in
[Ca
2+] in both AITC (1 mM)-sensitive and AITC-insensitive
DRG neurons cultured from wild-type mice.
(TIF)
Figure S2 Current-voltage relationships for DHA and
AITC in drosophila, zebrafish and mammalian TRPA1
channels. (A–D) I–V relationship for DHA (100 mM) and AITC
(1 mM) responses in HEK293 cells transfected with drosophila,
zebrafish A, zebrafish B, mouse, rat, or human TRPA1.
(TIF)
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